Brent L Wood
机构: Professor of Laboratory Medicine, Childrens Hospital Los Angeles
每年引用次数
引用次数
引用: 42,567
H-指数: 97
I10-指数 : 278
出版物: 626
High-dose chemo-radioimmunotherapy with autologous stem cell support for relapsed mantle cell lymphoma.
Ajay K. Gopal , Joseph G. Rajendran , Stephen H. Petersdorf , David G. Maloney
Blood 99 ( 9) 3158 -3162
194
2002
Minimal residual disease prior to allogeneic hematopoietic cell transplantation in acute myeloid leukemia: a meta-analysis
Sarah A. Buckley , Brent L. Wood , Megan Othus , Christopher S. Hourigan
Haematologica 102 ( 5) 865 -873
211
2017
Ultrasensitive detection of acute myeloid leukemia minimal residual disease using single molecule molecular inversion probes
Adam Waalkes , Kelsi Penewit , Brent L. Wood , David Wu
Haematologica 102 ( 9) 1549 -1557
18
2017
Impact of Minimal Residual Disease, As Detected by Multiparametric Flow Cytometry Pre and Post Transplantation, On Outcome of Myeloablative Hematopoietic Cell Transplantation for Acute Lymphoblastic Leukemia
Merav Bar , Brent L. Wood , Jerald P. Radich , Kristine C. Doney
Blood 120 ( 21) 592 -592
1
2012
Quantitative Significance of Minimal Residual Disease Before Myeloablative Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia in First and Second Complete Remission
Roland B. Walter , Sarah A. Buckley , John M. Pagel , Brent L. Wood
Blood 120 ( 21) 655 -655
2012
On-Going Evolution Of IGH In B-Cell Precursor Acute Lymphoblastic Leukemia Does Not Substantially Affect Day 29, Post-Treatment MRD Quantification By High-Throughput Sequencing
David Wu , Ryan O Emerson , Anna Sherwood , Mignon L. Loh
Blood 122 ( 21) 1341 -1341
2013
Flow cytometric detection of the classical hodgkin lymphoma: clinical and research applications.
Mikhail Roshal , Brent L. Wood , Jonathan R. Fromm
Advances in Hematology 2011 387034 -387034
12
2011
A phase I/II study of oral clofarabine plus low-dose cytarabine in previously treated acute myeloid leukaemia and high-risk myelodysplastic syndrome patients at least 60 years of age.
Sarah A. Buckley , Raya Mawad , Ted A. Gooley , Pamela S. Becker
British Journal of Haematology 170 ( 3) 349 -355
7
2015
Comparative analysis of flow cytometry and morphology for the detection of acute myeloid leukaemia cells in cerebrospinal fluid
Keith R. Loeb , Sindhu Cherian , Pamela S. Becker , Roland B. Walter
British Journal of Haematology 172 ( 1) 134 -136
5
2016
Phase II study of tosedostat with cytarabine or decitabine in newly diagnosed older patients with acute myeloid leukaemia or high-risk MDS.
Raya Mawad , Pamela S. Becker , Paul Hendrie , Bart Scott
British Journal of Haematology 172 ( 2) 238 -245
21
2016
Results of a phase I-II study of fenretinide and rituximab for patients with indolent B-cell lymphoma and mantle cell lymphoma.
Oliver W. Press , Ajay K. Gopal , Andrew J. Cowan , Phillip A. Stevenson
British Journal of Haematology 176 ( 4) 583 -590
6
2017
Anatomical compartments modify the response of human hematopoietic cells to a mitogenic signal.
Yasuo Nagasawa , Brent L. Wood , Linlin Wang , Ingrid Lintmaer
Stem Cells 24 ( 4) 908 -917
12
2006
Impact of minimal residual disease, detected by flow cytometry, on outcome of myeloablative hematopoietic cell transplantation for acute lymphoblastic leukemia.
Merav Bar , Brent L. Wood , Jerald P. Radich , Kristine C. Doney
Leukemia research and treatment 2014 421723 -421723
79
2014
Minimal Identifiable Disease and the Role of Conditioning Intensity in Hematopoietic Cell Transplantation for Myelodysplastic Syndrome and Acute Myelogenous Leukemia Evolving from Myelodysplastic Syndrome
Moreno Festuccia , H Joachim Deeg , Theodore A Gooley , Kelsey Baker
Biology of Blood and Marrow Transplantation 22 ( 7) 1227 -1233
18
2016
Multigene Measurable Residual Disease Assessment Improves Acute Myeloid Leukemia Relapse Risk Stratification in Autologous Hematopoietic Cell Transplantation
Matthew P. Mulé , Gabriel N. Mannis , Brent L. Wood , Jerald P. Radich
Biology of Blood and Marrow Transplantation 22 ( 11) 1974 -1982
14
2016
Allogeneic Hematopoietic Cell Transplantation (HCT) Yields Lower Relapse Rates but No Overall Survival Benefit for Adults with Acute Lymphoblastic Leukemia (ALL) in First Minimal Residual Disease (MRD)-Negative Remission
Ryan D. Cassaday , D. Alan Potts , Philip A. Stevenson , Merav Bar
Biology of Blood and Marrow Transplantation 21 ( 2)
2015
Impact of Pre-Transplant Minimal Residual Disease in Patients with AML Undergoing Myeloablative Cord Blood Transplantation
Filippo Milano , Brent L. Wood , Colleen Delaney
Biology of Blood and Marrow Transplantation 21 ( 2)
2015
Immune defects in a mouse model of Fanconi anaemia.
Sigrid C. Holmgren , Emily M. Goren , Brent L. Wood , Pamela S. Becker
British Journal of Haematology 159 ( 2) 246 -250
3
2012
Acute myeloid leukemia measurable residual disease detection by flow cytometry in peripheral blood vs bone marrow.
Colin Douglas Godwin , Yi Zhou , Megan Othus , Mallette M. Asmuth
Blood 137 ( 4) 569 -572
1
2021
Assessment of end induction minimal residual disease (MRD) in childhood B precursor acute lymphoblastic leukemia (ALL) to eliminate the need for day 14 marrow examination: A Children’s Oncology Group study.
Michael J. Borowitz , Brent L. Wood , Meenakshi Devidas , Mignon L. Loh
Journal of Clinical Oncology 31 10001 -10001
2
2013